Biggest News Aggregation in the World
📰 Confidence Interval News

Page 19 - Confidence Interval News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Confidence Interval. Real-time updates on events, politics, business and more.

Pegozafermin associated with improved outcomes in nonalcoholic steatohepatitis

1. In this randomized controlled trial, treatment with pegozafermin improved fibrosis in patients with nonalcoholic steatohepatitis (NASH). 2. Treatment with pegozafermin led to increased rates of NASH resolution. Evidence Rating Level: 1 (Excellent) Study Rundown: NASH is a disease characterized by hepatic inflammation and excess fat accumulation with or without fibrosis of the liver. Pegozafermin
Minute Medicine Inc Rating Level Controlled Trial Confidence Interval Chronic Disease Nonalcoholic Steatohepatitis Outcomes

Low achievement of guideline-recommended diabetes targets in Chinese adults

1. In this cross-sectional study, the proportion of Chinese adults with self-reported type 2 diabetes who achieved a guideline-recommended HbA1c target was 64.1%. 2. The proportion of Chinse adults with self-reported type 2 diabetes who achieved a guideline-recommended blood pressure was 22.2%. Evidence Rating Level: 1 (Excellent) Study Rundown: More than one-quarter of the Chinese
Effectiveness Of Team Minute Medicine Inc Rating Level Comparative Effectiveness Team Based Care With Clinical Decision Support System

Generic and brand-name fluticasone-salmeterol are equally effective in COPD management

1. In this cohort study, using generic versus brand-name fluticasone-salmeterol was associated with similar outcomes in chronic obstructive pulmonary disease (COPD) patients. 2. Using generic versus brand-name fluticasone-salmeterol was associated with no significant difference in the incidence of COPD exacerbations or pneumonia hospitalizations. Evidence Rating Level: 1 (Excellent) Study Rundown: Chronic obstructive pulmonary disease is
United States Wixela Inhub Advair Diskus Minute Medicine Inc Rating Level Drug Administration Approved

Adjunctive antidepressant maintenance ineffective in bipolar I depression

1. In this randomized controlled trial, adjunctive treatment with escitalopram or bupropion XL for 52 weeks was not superior to eight weeks in preventing relapse of mood episodes among patients with bipolar I depression. 2. The rates of adverse events were comparable across both approaches. Evidence Rating Level: 2 (Good) Study Rundown: Bipolar I disorder
Minute Medicine Inc Rating Level Confidence Interval Bipolar I Bipolari Depression Bupropion Xl

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

NaV1.8 inhibitor VX-548 reduces acute post-operative pain

1. In this randomized controlled trial, the elective NaV1.8 inhibitor VX-548 reduced acute pain over 48 hours following abdominoplasty and bunionectomy. 2. The main adverse events associated with VX-548 use were headaches and constipation. Evidence Rating Level: 1 (Excellent) Study Rundown: Acute pain, especially following traumas and surgical procedures, remains an area of unmet medical
Minute Medicine Inc Rating Level Numeric Pain Rating Scale Verbal Categorical Rating Scale Confidence Interval Chronic Disease

#VisualAbstract: Low-dose glucocorticoids for rheumatoid arthritis do not increase blood pressure

1. In this pooled analysis of randomized controlled trials, low-dose glucocorticoids taken over a two-year period did not increase patient blood pressure. 2. Low-dose glucocorticoid use was associated with an increase in weight of one kilogram on average. Evidence Rating Level: 1 (Excellent) Study Rundown: Glucocorticoids are commonly used in the management of rheumatoid arthritis (RA), though
Minute Medicine Inc Rating Level Low Dose Glucocorticoids Over Two Years Blood Pressure Confidence Interval

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science